Project Number GC-2012900 Agency/Funding Organization Alzheimer's Drug Discovery Foundation Funding Year 2016 View Full Project Details for BPN14770 Safety and Cognitive Benefit in Young and Elderly Subjects Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 7. Early-stage Clinical Drug Development (Phase I and II Clinical Trials) m. Synaptic Plasticity/Neuroprotection Researcher and Organization Principal Investigator Gurney, Mark Principal Investigator First Name Mark Principal Investigator Last Name Gurney Awardee Organization Tetra Discovery Partners Awardee State Michigan Contact PI Country United States Project Detail Funding Opportunity Announcement PACT Program FY Overall Cost $866,835 Funding Organization Agency/Funding Organization Alzheimer's Drug Discovery Foundation Funding Organization Country United States
